Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline add-on to antipsychotics in schizophrenia
NCT02907437Phase 3Unknown
- Sponsor
- Beer Yaakov - Ness Ziona Mental Health Center
- Start
- Jan 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of minocycline in schizophrenia, sponsored by Beer Yaakov - Ness Ziona Mental Health Center. Primary endpoint: Positive and Negative Syndrome Scale at 6 weeks. Status: unknown.
02
Drugs
minocycline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02907437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907437.